These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22399134)

  • 1. Development and validation of the current concept of major depression.
    Maj M
    Psychopathology; 2012; 45(3):135-46. PubMed ID: 22399134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Easing the burden of treatment-resistant depression.
    J Clin Psychiatry; 2009 Feb; 70(2):273-80. PubMed ID: 19265643
    [No Abstract]   [Full Text] [Related]  

  • 6. A tetrachoric factor analysis validation of mixed depression.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):186-92. PubMed ID: 17804137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and clinical utility of the current operational characterization of major depression.
    Maj M
    Int Rev Psychiatry; 2012 Dec; 24(6):530-7. PubMed ID: 23244608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is DSM-IV bereavement exclusion for major depression relevant to treatment response? A case-control, prospective study.
    Corruble E; Falissard B; Gorwood P
    J Clin Psychiatry; 2011 Jul; 72(7):898-902. PubMed ID: 21208577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melancholia agitata and mixed depression.
    Koukopoulos A; Sani G; Koukopoulos AE; Manfredi G; Pacchiarotti I; Girardi P
    Acta Psychiatr Scand Suppl; 2007; (433):50-7. PubMed ID: 17280571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit.
    Dowrick C; Frances A
    BMJ; 2013 Dec; 347():f7140. PubMed ID: 24322400
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinically useful depression outcome scale.
    Zimmerman M; Chelminski I; McGlinchey JB; Posternak MA
    Compr Psychiatry; 2008; 49(2):131-40. PubMed ID: 18243884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS; Benazzi F
    J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing major depressive disorder IV: relationship between number of symptoms and the diagnosis of disorder.
    Zimmerman M; McGlinchey JB; Young D; Chelminski I
    J Nerv Ment Dis; 2006 Jun; 194(6):450-3. PubMed ID: 16772864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Residual symptoms and recurrence in major depressive disorder].
    Spadone C; Corruble E
    Encephale; 2010 Dec; 36 Suppl 5():S108-11. PubMed ID: 21211628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and recurrence of late-life depression.
    Luijendijk HJ; van den Berg JF; Dekker MJ; van Tuijl HR; Otte W; Smit F; Hofman A; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2008 Dec; 65(12):1394-401. PubMed ID: 19047526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing major depressive disorder I: A psychometric evaluation of the DSM-IV symptom criteria.
    Zimmerman M; McGlinchey JB; Young D; Chelminski I
    J Nerv Ment Dis; 2006 Mar; 194(3):158-63. PubMed ID: 16534432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.